Paeds Vivas · mental-behavioural-and-psychosomatic
Obsessive-compulsive disorder in children — viva
Branching viva on paediatric OCD recognition, differential, stepped CBT-with-ERP care and refractory escalation.
On this page & tools
Target exams
Stem
Examiner-led viva on paediatric OCD. [22]
Examiner: How do you open this "lateness and anxiety" presentation? [22]
Strong answer: I greet the child first, then ask directly and privately about intrusive thoughts that keep coming back and rituals he performs to settle them — children hide obsessions, so I do not wait for him to volunteer them. I frame this as a full assessment, not a same-day label. [17] [22]
Examiner: He admits that unless his laces feel "just right" his mother will die. What defines this as OCD rather than a quirk? [22]
Strong answer: The impairing obsession–compulsion cycle: an intrusive, ego-dystonic thought (mother dies) drives a repetitive ritual (retying) that gives brief relief and restarts, consuming more than an hour a day and causing distress and impairment — unlike a normal ritual, which is enjoyed, time-limited and not impairing. [17] [22]
Examiner: Parents are now tying his laces for him. What is that, and does it help? [14]
Strong answer: That is family accommodation. It is well-intentioned but prevents extinction learning, maintains the cycle and predicts poorer response — so reducing accommodation (without blaming the parents) is an explicit treatment target within CBT/ERP, not a sustainable solution. [14]
Examiner: What is first-line treatment for moderate OCD? [1]
Strong answer: Cognitive–behavioural therapy with exposure and response prevention, roughly 12–16 sessions, is first-line and often effective without medication. The family is involved to reduce accommodation and support exposures. [1] [22]
Examiner: When and what do you add pharmacologically? [2]
Strong answer: For moderate-to-severe illness, partial ERP response, or significant comorbidity, I add an SSRI such as sertraline — start low, titrate over 6–10 weeks. POTS II showed CBT augmentation of an SSRI improves outcomes over SSRI alone, so ERP continues alongside. [2] [4]
Examiner: What suicidality counselling do you give? [5]
Strong answer: SSRIs carry a youth suicidality warning; I document baseline ideation, screen for bipolar history, and review mood and activation early and after dose changes. The absolute risk is small and outweighed by substantial OCD treatment benefit, so I do not let the warning deny effective care. [5]
Examiner: Refractory after ERP and two SSRIs? [8]
Strong answer: Maximise dose and duration, trial clomipramine with ECG and cardiac monitoring, escalate to intensive or family-based ERP, and refer to a specialist OCD service. [8]
Examiner: What if onset had been acute with choreiform movements and urinary frequency? [10]
Strong answer: That pattern suggests PANDAS/PANS. I would recognise the explosive onset, exclude streptococcal infection and neurological causes, and refer for specialist evaluation — routine antibiotics or immunomodulatory treatment are not standard general-paediatric practice. [10]
References
- [1]Pediatric OCD Treatment Study (POTS) Team Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA, 2004.PMID 15507582
- [2]Franklin ME Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. JAMA, 2011.PMID 21934055
- [4]March JS Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA, 1998.PMID 9842950
- [5]March JS Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents. Journal of child and adolescent psychopharmacology, 2006.PMID 16553531
- [8]DeVeaugh-Geiss J Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 1992.PMID 1537780
- [10]Swedo SE Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. The American journal of psychiatry, 1998.PMID 9464208
- [14]Farrell LJ Closing the Gap for Children with OCD: A Staged-Care Model of Cognitive Behavioural Therapy with Exposure and Response Prevention. Clinical child and family psychology review, 2023.PMID 37405675
- [17]Leonard HL Obsessive-compulsive disorder. Child and adolescent psychiatric clinics of North America, 2005.PMID 16171700
- [22]AACAP Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 2012.PMID 22176943